Delivery Order SPE2DB22D2214-SPE2DB25FS3EG

Award Date 12/30/24
Potential Completion Date 12/31/24
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $16,699.26, is for the delivery of Xarelto 20 mg tablets over a period ending on June 5, 2024. This contract is not designated as a set-aside award. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award from the Defense Logistics Agency (DLA) is a delivery order worth $12,401.73 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of the medication Xarelto 20 mg tablets, a cardiovascular drug, with a period of performance through February 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) worth up to $999,999,999 with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,660.17, is for the delivery of Xarelto 20 mg tablets. It is a Firm Fixed Price Delivery Order contract with an ultimate completion date of December 21, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,128.43, is for the delivery of Xarelto 20mg 90-count tablets. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $31,723.95 firm fixed-price delivery order is for Xarelto 20 mg tablets, a cardiovascular medication. The contract has an ultimate completion date of May 1, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,556.57 firm fixed-price delivery order is for the supply of XARELTO 20 MG TABLET 90S, with an ultimate completion date of June 3, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the leading global pharmaceutical company AmerisourceBergen Corporation. The $9,610.74 firm fixed price delivery order is for the supply of Xarelto 20 mg tablets to support military treatment programs and medical facilities. The award is associated with a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary contract vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order valued at $6,037.72 for the supply of Xarelto 20 mg tablets. The contract has an ultimate completion date of December 30, 2024 and is a firm fixed-price, non-set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is a delivery order valued at $43,156.71, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Xarelto 20 mg tablets, a cardiovascular medication. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $47,477.79, is for the delivery of Xarelto 20 mg tablets. This is a firm fixed-price delivery order contract with an ultimate completion date of September 25, 2023. The contract award is not designated as a set-aside and appears to be part of a larger Indefinite Delivery Contract (IDC) that...
  • SPE2DB22D2214
    Indefinite Delivery Contract
  • SPE2DB22D2214-SPE2DB25FS3EG
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,873.26, is a Firm Fixed Price Delivery Order for the provision of the drug Xarelto 20 mg Tablet 90s.

The award is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/21/25, 10:09 AM